The battle against stem cell hype: are we doing enough? can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?

<p style="text-align:justify;"> This article highlights the current controversies around stem cell research and its application in clinical medicine. It aims to discuss the ethical concerns around how corporate involvement is corrupting the ethical progression in this field of resea...

Full description

Bibliographic Details
Main Author: Burman, R
Format: Journal article
Published: Health and Medical Publishing Group 2014
_version_ 1797069312735838208
author Burman, R
author_facet Burman, R
author_sort Burman, R
collection OXFORD
description <p style="text-align:justify;"> This article highlights the current controversies around stem cell research and its application in clinical medicine. It aims to discuss the ethical concerns around how corporate involvement is corrupting the ethical progression in this field of research. The author appeals to medical and scientific communities to take cognisance of current practices and to facilitate the regulation of new stem cell therapies being advertised to the public. </p>
first_indexed 2024-03-06T22:22:35Z
format Journal article
id oxford-uuid:55906084-1dc5-4cc6-9f4a-5930c462d49a
institution University of Oxford
last_indexed 2024-03-06T22:22:35Z
publishDate 2014
publisher Health and Medical Publishing Group
record_format dspace
spelling oxford-uuid:55906084-1dc5-4cc6-9f4a-5930c462d49a2022-03-26T16:44:46ZThe battle against stem cell hype: are we doing enough? can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine? Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:55906084-1dc5-4cc6-9f4a-5930c462d49aSymplectic Elements at OxfordHealth and Medical Publishing Group2014Burman, R <p style="text-align:justify;"> This article highlights the current controversies around stem cell research and its application in clinical medicine. It aims to discuss the ethical concerns around how corporate involvement is corrupting the ethical progression in this field of research. The author appeals to medical and scientific communities to take cognisance of current practices and to facilitate the regulation of new stem cell therapies being advertised to the public. </p>
spellingShingle Burman, R
The battle against stem cell hype: are we doing enough? can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?
title The battle against stem cell hype: are we doing enough? can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?
title_full The battle against stem cell hype: are we doing enough? can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?
title_fullStr The battle against stem cell hype: are we doing enough? can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?
title_full_unstemmed The battle against stem cell hype: are we doing enough? can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?
title_short The battle against stem cell hype: are we doing enough? can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?
title_sort battle against stem cell hype are we doing enough can the medical and scientific community do more to support regulatory boards in advocating ethical evidence based medicine
work_keys_str_mv AT burmanr thebattleagainststemcellhypearewedoingenoughcanthemedicalandscientificcommunitydomoretosupportregulatoryboardsinadvocatingethicalevidencebasedmedicine
AT burmanr battleagainststemcellhypearewedoingenoughcanthemedicalandscientificcommunitydomoretosupportregulatoryboardsinadvocatingethicalevidencebasedmedicine